January 11, 2022 Dataset Open Access

Van Damme, Ellen

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Van Damme, Ellen</dc:creator>
  <dc:date>2022-01-11</dc:date>
  <dc:description>This short report describes the most relevant results of screening selected compounds from the Janssen Pharmaceutica compound collection in a VeroE6 cell-based anti-SARS-CoV-2 assay.</dc:description>
  <dc:identifier>https://zenodo.org/record/5838684</dc:identifier>
  <dc:identifier>10.5281/zenodo.5838684</dc:identifier>
  <dc:identifier>oai:zenodo.org:5838684</dc:identifier>
  <dc:relation>doi:10.5281/zenodo.5838683</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:title>Screening of 452 hit enrichment compounds for anti-SARS-CoV-2 activity meta data</dc:title>
  <dc:type>info:eu-repo/semantics/other</dc:type>
  <dc:type>dataset</dc:type>
</oai_dc:dc>